Drug class in one race
Voltage-gated sodium channel NaV1.8 drugs for Diabetic Peripheral Neuropathic Pain
3 tracked Voltage-gated sodium channel NaV1.8 drugs in the Diabetic Peripheral Neuropathic Pain race. The class explanation lives on the Voltage-gated sodium channel NaV1.8 page; the full indication pipeline across every mechanism is on the Diabetic Peripheral Neuropathic Pain page.
1 Phase 32 Phase 2
Head-to-head evidence: JMKX000623 vs Suzetrigine · JMKX000623 vs VX-993 · Suzetrigine vs VX-993